Abstract:Background: our recent discovery based on pharmacological experiment indicated that Gynostemma pentaphyllum (Gyp), an ingredient of Yinlan capsule can significanly accelerate the recovery of skeletal muscle for strain injury; and such effect was found to be based on inhibition of PXR-IL-6 expression. Purpose: to validate and investigate the PXR-IL-6 induced skeletal muscle recovery of Gyp, as well as its material basis by identification and determination of the herb's main active compounds both in-vitro and in-vivo. Methods: weight-drop model rats were used for evaluation of the recovery effect induced by Gyp, the animals were treated by orally administrating aqueous-ethanol (50:50. v/v) extract of Gyp in different dosages, and the results were compared with positive control (Celecoxib); a network pharmacology research was carried out to the main active target (s) of Gyp on strain injury recovery; Then, blood was taken from all experiment groups to test their values of PXR (by PCR) and IL-6 (by ELISA) expression, and statistically evaluated for the purpose of investigating Gyp's influence on PXR-IL-6 expression. At the meantime, Gyp extract was analyzed by a UPLC-TOF-MS method to identify its components; monomer solutions were prepared according to the results, and all found compounds were tested for their PXR-IL-6 regulation activities; those passing cyto-biological evaluation were introduced as indexes for content determination, and the pharmacokinetic analysis in the subsequent step; finally, the components with good regulatory effect, suitable herb and serum concentration, along with good pharmacokinetic profiles were recognized as active components, which comprise the material basis of Gyp's acceleration of strain injury recovery. Results: Gyp significantly promotes skeletal muscle recovery in all doses (p<0.05, compared with model), among which, the medium and high dosages (875, 1750mg.kg−1) had no obvious difference with positive control (p>0.05); the network pharmacological investigation indicated that PXR-IL-6 pathway was Gyp's main active one; In terms of PXR-IL-6 expression, Gyp effectively up-regulates the former and down-regulates the latter, which was comparable to that of the positive control; the UPLC-TOF-MS identification found 10 compounds, namely Rutin, Narcissoside, Quercetin, Isoquercitrin, Isorhamnetin, Linoleic acid, Kaempferol, GypenosideA, Gypenoside XVII and Gypenoside LXXIV, all of them except Rutin had obvious regulatory effect on PXR-IL-6 expression, and the trend of such regulation was in line with the herb extract; content determination and pharmacokinetic research showed that 5 of the 9 compounds had both suitable concentration in the extract and the serum, with good pharmacokinetic profiles, except quercetin and Isorhamnetin. Conclusion: Gyp effectively promotes skeletal muscle recovery via its activation of PXR and suppression of IL-6; such activity based on PXR-IL-6 regulatory components found in Gyp, its suggested that those active compounds be recognized as material basis explaining Gyp's therapeutic effect.

Gypenosides Ameliorate Morphine-Induced Immunosuppression with an Increased Proportion of Thymic T Lymphocyte Subsets and Are Involved in the Regulation of the Camp-Crem/creb-il-2 Pathway

Research Progress of Opioid Growth Factor in Immune-Related Diseases and Cancer Diseases

Compound 511 ameliorates MRSA-induced lung injury by attenuating morphine-induced immunosuppression in mice via PI3K/AKT/mTOR pathway

EFFECT OF MORPHINE AND ELECTRO-ACUPUNCTURE (EA) ON APOPTOSIS OF THYMOCYTES

Altered Membrane Expression and Function of CD11b Play a Role in the Immunosuppressive Effects of Morphine on Macrophages at the Nanomolar Level

Gypenoside induces apoptosis by inhibiting the PI3K/AKT/mTOR pathway and enhances T-cell antitumor immunity by inhibiting PD-L1 in gastric cancer

Gypenoside LXXV Alleviates Colitis by Reprograming Macrophage Polarization via the Glucocorticoid Receptor Pathway

Gynostemma Pentaphyllum Promotes Skeletal Muscle Recovery Via Its Inhibition of PXR-IL-6 Expression

Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway

Immunosuppression by opioids: Mechanisms of action on innate and adaptive immunity

Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis.

[The Effect of Melatonin on Enhancing Immune Function and Inhibiting the Ability of NO Over-Release in Morphine Dependent Mice].

Effect of Intrathecal Morphine and Electro-Acupuncture on Cellular Immune Function of Rats and Increment of Mu-Opioid Receptor Mrna Expression in PAG Following Intrathecal Morphine.

Effect of Electro-Acupuncture at ST36 and SP6 on the cAMP -CREB Pathway and mRNA Expression Profile in the Brainstem of Morphine Tolerant Mice

Neuroprotective effects of gypenosides on LPS-induced anxiety and depression-like behaviors

Gypenosides alleviate oxidative stress in the hippocampus, promote mitophagy, and mitigate depressive-like behaviors induced by CUMS via SIRT1

Gypenoside XVII, an Active Ingredient from Gynostemma Pentaphyllum, Inhibits C3aR-Associated Synaptic Pruning in Stressed Mice

Gypensapogenin I Ameliorates Isoproterenol (ISO)-Induced Myocardial Damage through Regulating the TLR4/NF-κB/NLRP3 Pathway

Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer

Suppressing High Mobility Group Box-1 Release Alleviates Morphine Tolerance Via the Adenosine 5'-Monophosphate-activated Protein Kinase/heme Oxygenase-1 Pathway.

Contribution of adrenomedullin to the switch of G protein-coupled μ-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats